PlainPharmaWatch

CMS Open Payments · Program Year 2024

Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals Inc. reported $434,435.40 across General Payments, Research, and Ownership to 748 physicians and teaching hospitals across 774 transactions.

See the rankings → How this is sourced
$434.4K
All-tracks total
774
Transactions
748
Recipients
−$510.9K
General Payments vs PY2023

Spectrum Pharmaceuticals Inc. reported $434,435.40 across all CMS Open Payments tracks (General + Research + Ownership) to 748 physicians and teaching hospitals in Program Year 2024 - ranking #801 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $38,714.11, averaging $580.80 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer spectrum-pharmaceuticals-inc Spectrum Pharmaceuticals Inc.

$434.4K · #801/1,925 · 0.0% industry · PY2024

  • TOT $434.4K
  • RANK #801
  • SHARE 0.0%
  • TXN 774
  • RCP 748
  • CAT 3
  • GEN $38.7K
  • ΔGEN −$510.9K
  • TOP1 20.6%
  • PY 2024

Volume peers

Nearest volume peer: NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. ($434.8K)

PhotoniCare Inc$437.5KPadagis US LLC$436.5KDelphinus Medical Technologi…$435.0KNeuroLogica Corporation, a s…$434.8KSpectrum Pharmaceuticals Inc…$434.4K
All-tracks payment totals near Spectrum Pharmaceuticals Inc. (CMS Open Payments PY2024)

Spectrum Pharmaceuticals Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Spectrum Pharmaceuticals Inc.'s CMS-reported General Payments decreased by $510.9K (−93.0%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2023: SPECTRUM PHARMACEUTICALS INC.PY2024: Spectrum Pharmaceuticals Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$549.7KPY2024$38.7K
PY2023
$549,654.76
PY2024
$38,714.11

What the Data Shows for Spectrum Pharmaceuticals Inc.

$434,435.40: that is what Spectrum Pharmaceuticals Inc. reported in payments to 748 physicians and teaching hospitals during Program Year 2024, spread across 774 transactions ($561.29 per transaction, $580.80 per recipient). The company sits at rank #801 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 3 general-payment categories charted below, "Food and Beverage" is the largest at $15.9K across 742 transactions, 41.1% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Food and Beverage" leads Spectrum Pharmaceuticals Inc.'s 3-category general-payment breakdown at $15.9K, 41.1% of the reported total.

How Spectrum Pharmaceuticals Inc. divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$15.9K2. Space Rental or Facility …$12.4K3. Consulting Fee$10.4K
Payment Type Amount Transactions
Food and Beverage $15.9K 742
Space Rental or Facility Fees $12.4K 2
Consulting Fee $10.4K 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $23,195.50 (59.9%) of $38,714.11 in this company's General Payments records across 573 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Spectrum Pharmaceuticals Inc.

The five named recipients with the highest reported General Payments from this company

Matthew Carlson$8.0KUh Cleveland Medical Center$7.4KOchsner Clinic Foundation$5.0KMichael Mcallister$2.6KJanelle Ashmore$191.25
  1. 1

    Matthew Carlson

    $7,976.25 across 5 reported transactions

  2. 2

    Uh Cleveland Medical Center

    $7,400.00 across 1 reported transactions

  3. 3

    Ochsner Clinic Foundation

    $5,000.00 across 1 reported transactions

  4. 4

    Michael Mcallister

    $2,628.00 across 3 reported transactions

  5. 5

    Janelle Ashmore

    $191.25 across 3 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Spectrum Pharmaceuticals Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Spectrum Pharmaceuticals Inc..

Orthalign Inc

HHI 1006

Lupin Inc.

HHI 1015

Canon Medical Informatics, Inc.

HHI 1001

Ortho Systems

HHI 1000

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Spectrum Pharmaceuticals Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Spectrum Pharmaceuticals Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.